A TUMOR'S growth rate is determined by its cellcycle time, growth fraction, and extent of cell loss (1) (2) (3) . Spontaneous cell loss represents a significant factor in the life history of many human and animal tumors (3) (4) (5) . Furthermore, nonneoplastic elements within a tumor possess kinetic characteristics that must be considered in any analysis of volumetric changes. Beyond the period of log phase growth, a solid tumor contains the following neoplastic and nonneoplastic components: tumor cells-I) living cells capable of unlimited cell division, 2) living cells without capacity to divide, 3) dead cells; host cells-I) monocytes, 2) phagocytes, 3) fibroblasts; other components-1) blood vessels, 2) stroma (noncellular components), 3) hemorrhage, 4) acellular debris.
Because necrotic tissue occupies a variable but significant volume in most malignant brain tumors, the rate of dead cell removal becomes an important factor in defining their kinetic behavior, particularly after treatment·induced cell death, e.g., chemotherapy. The present study was designed to develop a method for the investigation of the kinetics of dead cell removal in general and to compare the efficiencies of dead tumor-cell removal from brain, muscle, subcutaneous (sc) tissue, and peritoneal cavity.
Prusoff (6, 7) synthesized 131 2' -deoxy-5-iodouridine 131(IUDR) in 1959 and later demonstrated its incorporation into the DNA of mouse Ehrlich ascites cells. The stability of 125IUDR as a radiotracer for studying DNA metabolism (i.e., the label is not removed from intact DNA in living cells) was shown by Commerford (8) . Hofer et al. (9) and Dethlefsen (10) reported that only a small percentage of the incorporated IUDR is reutilized if the diet is supplemented with sodium iodide. Since the low energy X-ray from 125 1 can be detected with externally positioned gamma detectors, test animals need not be killed to study cell removal kinetics. Several investigators (8, (11) (12) (13) suggested that 125IUDR may be the compound of choice for following cell loss in vivo. However, results obtained here indicate that the in vivo loss of 126 1 from labeled dead tumor implants does not predict the rate of cell loss from the tissues in question.
MATERIALS AND METHODS
Weight reduction oj dead tumor.-Cells in flank glioma tumors were killed by 4 cycles of freezing (-80 0 C) and thawing (room temperature). The tumor was cut into 3-4 mm 3 pieces and weighed; the pieces were implanted into brain (20 rats), muscle (20 rats), and sc tissue (20 rats). Intracerebral implantation was performed with microneurosurgical techniques in rats anesthetized intraperitoneally (ip) with pentobarbital. A small craniectomy and partial removal of the frontal lobe were performed before the labeled tumor mass was implanted. Implantation of tumor into muscle and sc tissue was accomplished by simple surgical methods. Two or 3 rats in each group were killed at 2, 4, 7, 10, 14, 16, and 18 days after implantation. The implanted tumor, if any, was removed, weighed, and fixed in 10% formalin for histologic examination.
Labeling, cell killing, and implantation of tumor.-Tumors were grown in the flanks of male Fischer 344 rats by the injection of 10 6 syngeneic rat glioma cells. The characteristics of this tumor were reported (14) . When the tumor reached 8-10 mm in diameter, the tumor was labeled with four 250 p.Ci ip injections of 125IUDR at 6-hour intervals. One to 2 hours after the last dose, the tumor cells were killed by irradiation of the tumor in vivo with 5 krads of X-rays (300 kV, 20 rnA, HVL 1.62 mm Cu) or by at least 4 cycles of freezing (-80 0 C) and thawing (room temperature). The tumor was cut into 2-3 mm 3 pieces (30-100 mg) and then implanted into the white matter of brain (15 rats), sc tissue (15 rats), muscle (15 rats), and peritoneal cavity (15 rats).
The rats' drinking water was supplemented with 0.1 % sodium iodide 48 hours before implantation and continued until the end of the experiment. Immediately after tumor implantation and at daily intervals thereafter, whole-body radioactivity was monitored by placing individual live rats in a wholebody counting chamber (Tobar, Nuclear Chicago). Rats in plastic bags were placed in a small cardboard box during counting to avoid contamination of the chamber and excessive movements. All counts were corrected for radioactive decay by monitoring an appropriate standard of 1251. At the end of the experiment, rats were killed with pentobarbital ip, and the residual implanted tumor, if any, and thyroid gland were removed. Residual tumor fragments, thyroid glands, and the remaining carcasses were examined for radioactivity by the whole-body detection system.
Tumor and DNA 125[ activiry.-Flank tumors were prepared and labeled with 125IUDR as above. The cells were killed with 5 krads of X-rays and the tumor was minced into 3-4 mm 3 pieces weighing 50-150 mg. Two pieces of this labeled tumor were implanted into the sc tissue of 18 rats under ip pentobarbital anesthesia. Two rats were killed and the implanted tumor pieces were removed at intervals of 0, 2, 4, 6, 8, 10, 12, 18, and 24 hours post implantation. From each rat the DNA was extracted from 1 tumor piece by a modified SchmidtThannhauser technique (J 5) ; the second piece was dissolved in Soluene. The 125 1 activity in each of these pieces was determined in a Beckman LS-330 liquid scintillation spectrometer.
RESULTS

Dead Tumor Tissue Removal
All implanted tumors initially increased in weight (text- fig. 1 ) because of the imbibition of fluid. This increase reached a maximum in 3, 4, and 6 days for muscle, sc tissue, and brain, respectively; it was maximal in the sc tissue and minimal in the muscle. The tumor piece was virtually gone by day 8 in muscle, day 10 in sc tissue, and day 14 in brain.
Macroscopically, the implanted nonviable tumor had the following features. Within 12-24 hours, adhesions were noted between the implanted tumor and surrounding tissues, and the tumor piece was pale and swollen. 
1 Removal
The 125 1 activity in a typical tumor piece was =2000 counts per minute before it was rendered nonviable by X-irradiation or cycles of freeze-thawing. Over half this incorporated 125 1 activity was found in the acid-insoluble DNA fraction. When these tumor pieces were implanted, the removal of the 125 1 activity from the whole animal could be divided into 2 components (text- fig. 2 ). An initial rapid drop in the first 24 hours was followed by a more gradual loss over the next 230 hours. The rate of removal of 125 1 activity during the initial rapid decrease (0-24 hr) and during the subsequent slower decrease (24-230 hr) was similar for all the tissues. After 230 hours, the total 125 1 activity retained was greatest in the brain, slightly less in the peritoneal cavity, and least in the sc tissue and muscle. Unfortunately, when the DNA was isolated from Xirradiated tumor pieces 0-24 hours post implantation, most 125 1 activity was found in the acid-soluble fraction (text- fig. 3 ). Also, no residual 125 1 activity was observed in the remaining tumor pieces 24 hours post implantation or in any of the thyroids. Consequently, the slow depletion of 125 1 activity from the whole animal from 24 to 230 hours post implantation did not represent the rate of tumor cell loss from the tissue, but rather suggested that some reutilization of IUDR occurred under these experimental conditions.
DISCUSSION
1251U DR Studies
Using 1251UDR as a tracer for cell removal would allow one to follow the entire process in a single live animal and thereby eliminate the pitfalls associated with the killing of animals and removal of the tumor implant for gross morphologic and histologic measurements. Unfortunately, the loss of the 125 1 label from implanted dead tumor cells that had incorporated 1251UDR into their DNA before being killed proved an inaccurate tracer for the investigation of cell removal from any of the tissue systems. There were 2 components to the removal of 1251 activity from implanted dead tumor pieces: an initial rapid component and an extended slower component (text- fig. 2 ). Little 125 1 activity remained in the acid-insoluble DNA fraction extracted from dead tumor cells, even shortly after implantation (text- fig. 3 ).
The extended slower rate of removal could indicate that the transport of 1251UDR and/or IUDR-containing macromolecules from the brain and peritoneal cavity is slower than in muscle and sc tissue. However, if the reutilization of IUDR is primarily local in these tissues, it could also reflect the comparative turnover rates of the cells reincorporating the label. Less than 5% of the initial 1251 activity in the tumor cells remained in the DNA 20 hours post implantation (text- fig. 3 ). Consequently, removal of 125 1 activity from the tumor cell DNA does not explain the slow component in which 15-32% of the total activity is still present at 20 hours post implantation. Recently we showed that, during the first 24 hours after sham injections, a significant amount of the postsham, ipinjected 3H-thymidine is taken up by cells in the vicinity of the wound (16). Thus we favor reutilization by neighboring non-neoplastic cells as the more plausible explanation for the slow component, and conclude that, although the loss of 125 1 from 1251UDR incorporated into DNA may be a good indicator of cell death after a given treatment, it is doubtful if any experimental modification can make the technique applicable to the study of dead tumor cell removal in solid tumors. ., isolated tumor DNA.
Morphologic Studies
Theoretically cell loss in solid tumors occurs by 3 principal routes: a) Exfoliation from the primary tumor. Probably this is insignificant in primary brain tumors if the tumor is not in direct contact with the ventricles or the subarachnoid space. b) Spread of cells within the body, particularly through vascular and lymphatic systems. Unlike other tissues of the body, the central nervous system (CNS) possesses no lymphatic system. Distant metastasis from the braia via vascular channels is rare, and most of these metastases have followed surgical procedures (17) . c) Phagocytosis of dead cells. In malignant CNS tumors, macrophages are observed in most necrotic areas. The efficiency with which these macrophages remove dead cell debris is not known accurately, but unquestionably necrotic debris constitutes a major component of solid brain tumors.
Necrotic tumor cells add to the mass effect, and if not promptly removed from the CNS, a small increase in tumor size caused by swelling of the nonviable cell compartment may seriously threaten already compromised neural function. An additional elevation of an already raised intracranial pressure may cause death by medullary compression.
Living tissues react to a mass of dead tissues in two phases. In the first active phase, many materials, both irritating and nonirritating, diffuse from the dead tumor. These substances incite an acute inflammatory reaction and possibly impair the bloodbrain barrier in adjacent brain. Products of disintegration may also stimulate new blood vessel formation, resembling the effect of angiogenesis factor found in certain growing tumors (18) .
In the second phase, a change from the acute inflammatory process to a repair process is exemplified by the infiltration of fibroblasts and the laying down of collagen. These findings are consistent with similar studies on normal liver implants in the peritoneal cavity (19) . In our experimental model, the necrotic tumor and the reaction secondary to the implant persisted 8-12 days (text- fig. 1 ). Considering that the implanted pieces weighed only 50-150 mg, cell disposal seems to be a slow process, particularly in the brain. At the end of 9 days post implantation, 65% of the implanted tumor weight was still present in the brain, compared with 40% in the sc tissue, and 6% in the muscle. Because of the limited volume of the cranial cavity, this slow rate of dead cell removal from the brain magnifies the mass effect of a brain tumor.
Therapeutically, these results have important ramifications. However, caution should be exercised when results are extrapolated from an implanted tumor that develops neovascularization to a primary brain tumor which develops neovascularization in addition to its own vascularity. Effective treatment of brain tumors with either radiotherapy or chemotherapy causes cell death. Our experiment suggests that the initial increase in tumor weight is the result of imbibition of fluid rather than the presence of necrotic tissue. This is consistent with the clinical worsening observed during radiation therapy and after effective chemotherapy for brain tumors. Areas of necrosis, abundant in malignant brain tumors, seem to be more extensive after therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea (14) , and an initial clinical worsening should be anticipated as an undesired consequence of effective therapy. The administration of dexamethasone and osmotic agents may ameliorate the post-treatment increase in tumor mass, but it may be insufficient under certain circumstances.
The poor results obtained with chemotherapy of large brain tumors and the observation of late responders after as many as three courses of chemotherapy are more consistent with the slow dead cell removal observed in these experiments than with a purported slow antitumor effect of the primary agent. It is, therefore, important to search for ways to directly influence the cell removal system and thus improve the efficiency of chemotherapeutic agents. In considering the response of a solid malignant brain tumor to therapy, one should not ignore this slow disposal of dead cells, and future clinical protocols might be designed with this factor in mind. 
